Thakur Lab
northeastern home | bouve home


Inspire Engage Learn

The Thakur Lab came into existence in August 2010. Here, research has a multi-dimensional aspect with a focus on treating a plethora of diseases and disorders. We make this possible by targeting receptors like cannabinoid, nicotinic and other protein complexes. Through this approach we intend to design a pharmacotherapy for Alzheimer's disease, schizophrenia, anorexia nervosa, glaucoma, obesity and post-traumatic stress disorder. In order to execute this task we have the support of a strong team of collaborators from around the world. The order of research includes synthesis of potent and selective compounds for a target, their in-vitro and in-vivo studies and application of the knowledge acquired for a detailed and rational structure-activity relationship studies.


Dr. Thakur recently received a NIH grant for executing his work towards a novel pharmacotherapy for Glaucoma.
Glaucoma is a group of diseases that damage the eye’s optic nerve and can result in vision loss and blindness. However, with early detection and treatment, you can often protect your eyes against serious vision loss. He is a PI on this grant and has received the funding for 5 years.